- Product Id: AIMR 1448 | Pages: 200 | Publish Date: Jun 2001 | Category: Healthcare
"Increasing number of target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement policies are major factors driving the market growth. Global Embolotherapy Market is valued at USD 3125.7 Million in 2018 and expected to reach USD 5461.9 Million by 2025 with the CAGR of 8.30% over the forecast period. Scope of The Report: Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors. Embolotherapy is a type of endovascular treatment that aims to block abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumors and much more. To achieve blocking, embolotherapy performs minimally-invasive methods and several embolic agents, such as gelfoam, coils, balloons and angiographic catheters to reach exact and significant results. The embolic agents used can be either temporary or permanent and are determined according to the clinical application, and thus can differ greatly from case to case. Embolotherapies have become mainstays of interventional radiology practice. In order to achieve embolotherapy properly, IRs must be qualified, up-to-date on the modern data, aware with fundamental pathologies and well-informed on how other specialties can also contribute to patient treatment. Global embolotherapy market report is segmented on the basis of product, disease indication, procedure, end-user and region & country level. Based on product, global embolotherapy market is classified into embolic agents, microspheres, embolic coils, liquid embolic agents, embolic plug systems, detachable balloons, support devices, microcatheters and guidewires. Based on disease indication, global embolotherapy market is classified into cancer, liver cancer, kidney cancer, other cancers, peripheral vascular diseases, neurological diseases, cerebral aneurysm, cerebral arteriovenous malformations and fistulas, gastrointestinal disorders, and urological and nephrological disorders. Based on procedure, the market is classified into transcatheter arterial embolization, transcatheter arterial radio embolization/selective internal radiation therapy, and transarterial chemoembolization. Based on end-user, global embolotherapy market is classified into hospitals and clinics, ambulatory surgical centers and others. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Embolotherapy Market. Key Benefits for Embolotherapy Market Reports Global market report covers in-depth historical and forecast analysis. Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. Global market report helps to identify opportunities in market place. Global market report covers extensive analysis of emerging trends and competitive landscape. Embolotherapy Market Segmentation: By Product: Embolic agents Microspheres Embolic coils o Detachable Coils o Pushable Coils Liquid Embolic Agents Embolic Plug Systems Detachable Balloons Support Devices Microcatheters Guidewires By Disease Indication: Cancer Liver Cancer Kidney Cancer Other Cancers Peripheral Vascular Diseases Neurological Diseases Cerebral Aneurysm Cerebral Arteriovenous Malformations and Fistulas Gastrointestinal Disorders Urological and Nephrological Disorders By Procedure: Transcatheter Arterial Embolization Transcatheter Arterial Radio embolization/Selective Internal Radiation Therapy Transarterial Chemoembolization By End-User: Hospitals and Clinics Ambulatory Surgical Centers Other By Region North America USA Canada Mexico Europe UK France Germany Russia Rest of Europe Asia-Pacific China South Korea India Japan Rest of Asia-Pacific LAMEA Latin America Middle East Africa Embolotherapy Market Key Players: Boston Scientific Corporation Merit Medical Systems Terumo Corporation Medtronic plc, Johnson & Johnson Stryker Corporation BTG plc, Penumbra, Inc. Cook Medical Abbott Laboratories Acandis GmbH BALT Extrusion Sirtex Medical Limited Kaneka Corporation Meril Life Sciences Pvt. Ltd. This comprehensive report will provide: Enhance your strategic decision making Assist with your research, presentations and business plans Show which emerging market opportunities to focus on Increase your industry knowledge Keep you up-to-date with crucial market developments Allow you to develop informed growth strategies Build your technical insight Illustrate trends to exploit Strengthen your analysis of competitors Provide risk analysis, helping you avoid the pitfalls other companies could make Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: Which are the driving factors responsible for the growth of market? Which are the roadblock factors of this market? What are the new opportunities, by which market will grow in coming years? What are the trends of this market? Which are main factors responsible for new product launch? How big is the global & regional market in terms of revenue, sales and production? How far will the market grow in forecast period in terms of revenue, sales and production? Which region is dominating the global market and what are the market shares of each region in the overall market in 2019? How will each segment grow over the forecast period and how much revenue will these segment account for in 2027? Which region has more opportunities?"
Table of Content
1. Chapter - Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USPâ€™s of Report
1.8. Report Description
2. Chapter Global Embolotherapy Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Embolotherapy Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Embolotherapy Market: Trends
2.8. Porterâ€™s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter - Global Embolotherapy Market Overview: Quantitative Analysis
3.1. Global Embolotherapy Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2016- 2027
3.2. Global Embolotherapy Market Revenue Market Share (%), 2016- 2027
3.3. Global Embolotherapy Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2016- 2027
3.4. Global Embolotherapy Market Sales Market Share (%), 2016- 2027
4. Chapter Global Embolotherapy Market Analysis: Segmentation By Type
5. Chapter Global Embolotherapy Market Analysis: Segmentation By Application
6. Chapter - Global Embolotherapy Market Analysis: By Manufacturer
6.1. Global Embolotherapy Market Revenue (USD Million), by Manufacturer, 2016 - 2027
6.2. Global Embolotherapy Market Share (%), by Manufacturer, 2018
6.3. Global Embolotherapy Market Sales (Number of Units), by Manufacturer, 2016 - 2027
6.4. Global Embolotherapy Market Share (%), by Manufacturer, 2018
6.5. Global Embolotherapy Market Price (USD/Unit), by Manufacturer, 2016 - 2027
6.6. Global Embolotherapy Market Revenue Growth Rate (%), by Manufacturer, 2016 2027
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
7. Chapter Embolotherapy Market: Regional Analysis
7.1. North America
7.1.1. North America Embolotherapy Market Revenue (USD Million) and Growth Rate (%), 2016 2027.
7.1.2. North America Embolotherapy Market Revenue (USD Million) By Country, 2016 2027.
7.1.3. North America Embolotherapy Revenue Market Share (%) By Country, 2016 2027.
7.1.4. North America Embolotherapy Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2016 2027.
7.1.5. North America Embolotherapy Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2016 2027.
7.1.6. North America Embolotherapy Market Sales (Number of Units) and Growth Rate (%), 2016 2027.
7.1.7. North America Embolotherapy Market Sales (Number of Units) By Country, 2016 2027.
7.1.8. North America Embolotherapy Sales Market Share (%) By Country, 2016 2027.
7.1.9. North America Embolotherapy Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2016 2027.
7.1.10. North America Embolotherapy Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2016 2027.
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Chapter - Company Profiles
Embolotherapy Market Size By Type (Embolic agents, Microspheres, Embolic coils, Detachable Coils, Pushable Coils, Liquid Embolic Agents, Embolic Plug Systems, Detachable Balloons, Support Devices, Microcatheters, Guidewires), By Disease Indication (Cancer, Liver Cancer, Kidney Cancer, Other Cancers, Peripheral Vascular Diseases, Neurological Diseases, Cerebral Aneurysm, Cerebral Arteriovenous Malformations and Fistulas, Gastrointestinal Disorders, Urological and Nephrological Disorders) Forecast to 2021 - 2027